The company will acquire the equity interests of SPG in the joint venture between DSM and SPG in a US$13.8 million deal.
28/01/05 Royal DSM N.V. has reached principal agreement with Shanghai Pharmaceutical Group (SPG) in Shanghai, China to acquire the equity interests of SPG in the joint venture between DSM and SPG, named Roche (Shanghai) Vitamins Limited (RSVL) in a US$13.8 million deal. After this acquisition of the 36% share participation of SPG, RSVL will be a wholly owned subsidiary of DSM (Nutritional Products) and in due course will be renamed DSM Vitamins (Shanghai) Ltd.). With this step DSM has further strengthened its position in the Chinese vitamin market. RSVL is engaged in the production of Vitamin A, Vitamin E, Vitamin B6 and vitamin blends for the animal and human nutrition markets. The company operates from two sites in Shanghai and sells products both in the domestic Chinese market and also exports certain products to other parts of the world.
